Synthesis and In vitro cytotoxic activity evaluation of (E)-16-(substituted benzylidene) derivatives of dehydroepiandrosterone

Background and the purpose of the study Modified androsterone derivatives are class of steroidal compounds with potential anticancer properties. Various steroidal derivatives containing substitution at position 16 have shown diversified pharmacological activities. In the present study, a new series...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Daru 2013-05, Vol.21 (1), p.34-34, Article 34
Hauptverfasser: Vosooghi, Mohsen, Yahyavi, Hoda, Divsalar, Kouros, Shamsa, Hashem, Kheirollahi, Asma, Safavi, Maliheh, Ardestani, Sussan Kabudanian, Sadeghi-Neshat, Sareh, Mohammadhosseini, Negar, Edraki, Najmeh, Khoshneviszadeh, Mehdi, Shafiee, Abbas, Foroumadi, Alireza
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 34
container_issue 1
container_start_page 34
container_title Daru
container_volume 21
creator Vosooghi, Mohsen
Yahyavi, Hoda
Divsalar, Kouros
Shamsa, Hashem
Kheirollahi, Asma
Safavi, Maliheh
Ardestani, Sussan Kabudanian
Sadeghi-Neshat, Sareh
Mohammadhosseini, Negar
Edraki, Najmeh
Khoshneviszadeh, Mehdi
Shafiee, Abbas
Foroumadi, Alireza
description Background and the purpose of the study Modified androsterone derivatives are class of steroidal compounds with potential anticancer properties. Various steroidal derivatives containing substitution at position 16 have shown diversified pharmacological activities. In the present study, a new series of cytotoxic 16-(substituted benzylidene) derivatives of dehydroepiandrosterone (DHEA) were synthesized and evaluated against three different cancer cell lines. Methods The cytotoxic 16-(substituted benzylidene) derivatives of DHEA were synthesized via aldol condensation of DHEA with corresponding benzaldehyde derivatives. The cytotoxic activity of synthesized derivatives was evaluated against three different cancer cells including KB, T47D and SK-N-MC cell lines by MTT reduction colorimetric assay. Results The results indicated that 16-(substituted benzylidene) derivatives of DHEA could be served as a potent anti-cancer agent. The 3-cholro benzylidene derivatives of DHEA was the most potent synthesized derivative especially against KB and T47D cell lines (IC 50 values were 0.6 and 1.7 μM; respectively). Conclusion The cytotoxic potential of novel benzylidene derivatives of DHEA is mainly attributed to the position and nature of the substituted group on the benzylidene pendant.
doi_str_mv 10.1186/2008-2231-21-34
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3673839</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A534834387</galeid><sourcerecordid>A534834387</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-f655581e71b8a8d946c9509d81cd5d1a0450ad8008ffb90c4d618c5383e77bd3</originalsourceid><addsrcrecordid>eNp1kUFv1DAQRi0EotvCmRvKCW0PoXYcO84FqapaqFSJA71bjj3ZuMrai-1EhAO_HUdbVnDgZGnm6XlmPoTeEfyREMGvKoxFWVWUlBUpaf0CbU6Vl2hDGMelIISdofMYnzCmoubVa3RWUU4ZJmSDfn1bXBog2lgoZ4p7V8w2BV_oJfnkf1hdKJ1sri0FzGqcVLLeFb4vtreXJeHlNk5dTDZNCUzRgfu5jNaAg8vCQLBzxmeIK29gWEzwcLD5n-BjguAdvEGvejVGePv8XqDHu9vHmy_lw9fP9zfXD6WuOUtlzxljgkBDOqGEaWuuW4ZbI4g2zBCFa4aVEXn1vu9arGvDidCMCgpN0xl6gT4dtYep24PR4FJQozwEu1dhkV5Z-W_H2UHu_Cwpb7KkzYLtsyD47xPEJPc2ahhH5cBPURKaJ8SiIXVGPxzRnRpBDqDGNEQ_TuvhorxmtBa0pqLJ4NUR1PkcMUB_modguaYr1yzlmqWsiKSr-v3fa5z4P3FmAB-BmFtuB0E--Sm4fNn_On8DohuxFw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1365508714</pqid></control><display><type>article</type><title>Synthesis and In vitro cytotoxic activity evaluation of (E)-16-(substituted benzylidene) derivatives of dehydroepiandrosterone</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><source>SpringerLink Journals - AutoHoldings</source><creator>Vosooghi, Mohsen ; Yahyavi, Hoda ; Divsalar, Kouros ; Shamsa, Hashem ; Kheirollahi, Asma ; Safavi, Maliheh ; Ardestani, Sussan Kabudanian ; Sadeghi-Neshat, Sareh ; Mohammadhosseini, Negar ; Edraki, Najmeh ; Khoshneviszadeh, Mehdi ; Shafiee, Abbas ; Foroumadi, Alireza</creator><creatorcontrib>Vosooghi, Mohsen ; Yahyavi, Hoda ; Divsalar, Kouros ; Shamsa, Hashem ; Kheirollahi, Asma ; Safavi, Maliheh ; Ardestani, Sussan Kabudanian ; Sadeghi-Neshat, Sareh ; Mohammadhosseini, Negar ; Edraki, Najmeh ; Khoshneviszadeh, Mehdi ; Shafiee, Abbas ; Foroumadi, Alireza</creatorcontrib><description>Background and the purpose of the study Modified androsterone derivatives are class of steroidal compounds with potential anticancer properties. Various steroidal derivatives containing substitution at position 16 have shown diversified pharmacological activities. In the present study, a new series of cytotoxic 16-(substituted benzylidene) derivatives of dehydroepiandrosterone (DHEA) were synthesized and evaluated against three different cancer cell lines. Methods The cytotoxic 16-(substituted benzylidene) derivatives of DHEA were synthesized via aldol condensation of DHEA with corresponding benzaldehyde derivatives. The cytotoxic activity of synthesized derivatives was evaluated against three different cancer cells including KB, T47D and SK-N-MC cell lines by MTT reduction colorimetric assay. Results The results indicated that 16-(substituted benzylidene) derivatives of DHEA could be served as a potent anti-cancer agent. The 3-cholro benzylidene derivatives of DHEA was the most potent synthesized derivative especially against KB and T47D cell lines (IC 50 values were 0.6 and 1.7 μM; respectively). Conclusion The cytotoxic potential of novel benzylidene derivatives of DHEA is mainly attributed to the position and nature of the substituted group on the benzylidene pendant.</description><identifier>ISSN: 1560-8115</identifier><identifier>ISSN: 2008-2231</identifier><identifier>EISSN: 2008-2231</identifier><identifier>DOI: 10.1186/2008-2231-21-34</identifier><identifier>PMID: 23635011</identifier><language>eng</language><publisher>London: BioMed Central</publisher><subject>Aldehydes ; Biomedical and Life Sciences ; Biomedicine ; Cancer ; Care and treatment ; Dehydroepiandrosterone ; Hormones, Sex ; Medicinal Chemistry ; Pharmaceutical Sciences/Technology ; Pharmacology/Toxicology ; Research Article ; Structure-activity relationships (Biochemistry)</subject><ispartof>Daru, 2013-05, Vol.21 (1), p.34-34, Article 34</ispartof><rights>Vosooghi et al.; licensee BioMed Central Ltd. 2013. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>COPYRIGHT 2013 BioMed Central Ltd.</rights><rights>Copyright © 2013 Vosooghi et al.; licensee BioMed Central Ltd. 2013 Vosooghi et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-f655581e71b8a8d946c9509d81cd5d1a0450ad8008ffb90c4d618c5383e77bd3</citedby><cites>FETCH-LOGICAL-c465t-f655581e71b8a8d946c9509d81cd5d1a0450ad8008ffb90c4d618c5383e77bd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673839/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673839/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,27929,27930,41493,42562,51324,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23635011$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vosooghi, Mohsen</creatorcontrib><creatorcontrib>Yahyavi, Hoda</creatorcontrib><creatorcontrib>Divsalar, Kouros</creatorcontrib><creatorcontrib>Shamsa, Hashem</creatorcontrib><creatorcontrib>Kheirollahi, Asma</creatorcontrib><creatorcontrib>Safavi, Maliheh</creatorcontrib><creatorcontrib>Ardestani, Sussan Kabudanian</creatorcontrib><creatorcontrib>Sadeghi-Neshat, Sareh</creatorcontrib><creatorcontrib>Mohammadhosseini, Negar</creatorcontrib><creatorcontrib>Edraki, Najmeh</creatorcontrib><creatorcontrib>Khoshneviszadeh, Mehdi</creatorcontrib><creatorcontrib>Shafiee, Abbas</creatorcontrib><creatorcontrib>Foroumadi, Alireza</creatorcontrib><title>Synthesis and In vitro cytotoxic activity evaluation of (E)-16-(substituted benzylidene) derivatives of dehydroepiandrosterone</title><title>Daru</title><addtitle>DARU J Pharm Sci</addtitle><addtitle>Daru</addtitle><description>Background and the purpose of the study Modified androsterone derivatives are class of steroidal compounds with potential anticancer properties. Various steroidal derivatives containing substitution at position 16 have shown diversified pharmacological activities. In the present study, a new series of cytotoxic 16-(substituted benzylidene) derivatives of dehydroepiandrosterone (DHEA) were synthesized and evaluated against three different cancer cell lines. Methods The cytotoxic 16-(substituted benzylidene) derivatives of DHEA were synthesized via aldol condensation of DHEA with corresponding benzaldehyde derivatives. The cytotoxic activity of synthesized derivatives was evaluated against three different cancer cells including KB, T47D and SK-N-MC cell lines by MTT reduction colorimetric assay. Results The results indicated that 16-(substituted benzylidene) derivatives of DHEA could be served as a potent anti-cancer agent. The 3-cholro benzylidene derivatives of DHEA was the most potent synthesized derivative especially against KB and T47D cell lines (IC 50 values were 0.6 and 1.7 μM; respectively). Conclusion The cytotoxic potential of novel benzylidene derivatives of DHEA is mainly attributed to the position and nature of the substituted group on the benzylidene pendant.</description><subject>Aldehydes</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Dehydroepiandrosterone</subject><subject>Hormones, Sex</subject><subject>Medicinal Chemistry</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Pharmacology/Toxicology</subject><subject>Research Article</subject><subject>Structure-activity relationships (Biochemistry)</subject><issn>1560-8115</issn><issn>2008-2231</issn><issn>2008-2231</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><recordid>eNp1kUFv1DAQRi0EotvCmRvKCW0PoXYcO84FqapaqFSJA71bjj3ZuMrai-1EhAO_HUdbVnDgZGnm6XlmPoTeEfyREMGvKoxFWVWUlBUpaf0CbU6Vl2hDGMelIISdofMYnzCmoubVa3RWUU4ZJmSDfn1bXBog2lgoZ4p7V8w2BV_oJfnkf1hdKJ1sri0FzGqcVLLeFb4vtreXJeHlNk5dTDZNCUzRgfu5jNaAg8vCQLBzxmeIK29gWEzwcLD5n-BjguAdvEGvejVGePv8XqDHu9vHmy_lw9fP9zfXD6WuOUtlzxljgkBDOqGEaWuuW4ZbI4g2zBCFa4aVEXn1vu9arGvDidCMCgpN0xl6gT4dtYep24PR4FJQozwEu1dhkV5Z-W_H2UHu_Cwpb7KkzYLtsyD47xPEJPc2ahhH5cBPURKaJ8SiIXVGPxzRnRpBDqDGNEQ_TuvhorxmtBa0pqLJ4NUR1PkcMUB_modguaYr1yzlmqWsiKSr-v3fa5z4P3FmAB-BmFtuB0E--Sm4fNn_On8DohuxFw</recordid><startdate>20130501</startdate><enddate>20130501</enddate><creator>Vosooghi, Mohsen</creator><creator>Yahyavi, Hoda</creator><creator>Divsalar, Kouros</creator><creator>Shamsa, Hashem</creator><creator>Kheirollahi, Asma</creator><creator>Safavi, Maliheh</creator><creator>Ardestani, Sussan Kabudanian</creator><creator>Sadeghi-Neshat, Sareh</creator><creator>Mohammadhosseini, Negar</creator><creator>Edraki, Najmeh</creator><creator>Khoshneviszadeh, Mehdi</creator><creator>Shafiee, Abbas</creator><creator>Foroumadi, Alireza</creator><general>BioMed Central</general><general>BioMed Central Ltd</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130501</creationdate><title>Synthesis and In vitro cytotoxic activity evaluation of (E)-16-(substituted benzylidene) derivatives of dehydroepiandrosterone</title><author>Vosooghi, Mohsen ; Yahyavi, Hoda ; Divsalar, Kouros ; Shamsa, Hashem ; Kheirollahi, Asma ; Safavi, Maliheh ; Ardestani, Sussan Kabudanian ; Sadeghi-Neshat, Sareh ; Mohammadhosseini, Negar ; Edraki, Najmeh ; Khoshneviszadeh, Mehdi ; Shafiee, Abbas ; Foroumadi, Alireza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-f655581e71b8a8d946c9509d81cd5d1a0450ad8008ffb90c4d618c5383e77bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aldehydes</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Dehydroepiandrosterone</topic><topic>Hormones, Sex</topic><topic>Medicinal Chemistry</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Pharmacology/Toxicology</topic><topic>Research Article</topic><topic>Structure-activity relationships (Biochemistry)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vosooghi, Mohsen</creatorcontrib><creatorcontrib>Yahyavi, Hoda</creatorcontrib><creatorcontrib>Divsalar, Kouros</creatorcontrib><creatorcontrib>Shamsa, Hashem</creatorcontrib><creatorcontrib>Kheirollahi, Asma</creatorcontrib><creatorcontrib>Safavi, Maliheh</creatorcontrib><creatorcontrib>Ardestani, Sussan Kabudanian</creatorcontrib><creatorcontrib>Sadeghi-Neshat, Sareh</creatorcontrib><creatorcontrib>Mohammadhosseini, Negar</creatorcontrib><creatorcontrib>Edraki, Najmeh</creatorcontrib><creatorcontrib>Khoshneviszadeh, Mehdi</creatorcontrib><creatorcontrib>Shafiee, Abbas</creatorcontrib><creatorcontrib>Foroumadi, Alireza</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Daru</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vosooghi, Mohsen</au><au>Yahyavi, Hoda</au><au>Divsalar, Kouros</au><au>Shamsa, Hashem</au><au>Kheirollahi, Asma</au><au>Safavi, Maliheh</au><au>Ardestani, Sussan Kabudanian</au><au>Sadeghi-Neshat, Sareh</au><au>Mohammadhosseini, Negar</au><au>Edraki, Najmeh</au><au>Khoshneviszadeh, Mehdi</au><au>Shafiee, Abbas</au><au>Foroumadi, Alireza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and In vitro cytotoxic activity evaluation of (E)-16-(substituted benzylidene) derivatives of dehydroepiandrosterone</atitle><jtitle>Daru</jtitle><stitle>DARU J Pharm Sci</stitle><addtitle>Daru</addtitle><date>2013-05-01</date><risdate>2013</risdate><volume>21</volume><issue>1</issue><spage>34</spage><epage>34</epage><pages>34-34</pages><artnum>34</artnum><issn>1560-8115</issn><issn>2008-2231</issn><eissn>2008-2231</eissn><abstract>Background and the purpose of the study Modified androsterone derivatives are class of steroidal compounds with potential anticancer properties. Various steroidal derivatives containing substitution at position 16 have shown diversified pharmacological activities. In the present study, a new series of cytotoxic 16-(substituted benzylidene) derivatives of dehydroepiandrosterone (DHEA) were synthesized and evaluated against three different cancer cell lines. Methods The cytotoxic 16-(substituted benzylidene) derivatives of DHEA were synthesized via aldol condensation of DHEA with corresponding benzaldehyde derivatives. The cytotoxic activity of synthesized derivatives was evaluated against three different cancer cells including KB, T47D and SK-N-MC cell lines by MTT reduction colorimetric assay. Results The results indicated that 16-(substituted benzylidene) derivatives of DHEA could be served as a potent anti-cancer agent. The 3-cholro benzylidene derivatives of DHEA was the most potent synthesized derivative especially against KB and T47D cell lines (IC 50 values were 0.6 and 1.7 μM; respectively). Conclusion The cytotoxic potential of novel benzylidene derivatives of DHEA is mainly attributed to the position and nature of the substituted group on the benzylidene pendant.</abstract><cop>London</cop><pub>BioMed Central</pub><pmid>23635011</pmid><doi>10.1186/2008-2231-21-34</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1560-8115
ispartof Daru, 2013-05, Vol.21 (1), p.34-34, Article 34
issn 1560-8115
2008-2231
2008-2231
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3673839
source EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry; SpringerLink Journals - AutoHoldings
subjects Aldehydes
Biomedical and Life Sciences
Biomedicine
Cancer
Care and treatment
Dehydroepiandrosterone
Hormones, Sex
Medicinal Chemistry
Pharmaceutical Sciences/Technology
Pharmacology/Toxicology
Research Article
Structure-activity relationships (Biochemistry)
title Synthesis and In vitro cytotoxic activity evaluation of (E)-16-(substituted benzylidene) derivatives of dehydroepiandrosterone
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T02%3A47%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20In%20vitro%20cytotoxic%20activity%20evaluation%20of%20(E)-16-(substituted%20benzylidene)%20derivatives%20of%20dehydroepiandrosterone&rft.jtitle=Daru&rft.au=Vosooghi,%20Mohsen&rft.date=2013-05-01&rft.volume=21&rft.issue=1&rft.spage=34&rft.epage=34&rft.pages=34-34&rft.artnum=34&rft.issn=1560-8115&rft.eissn=2008-2231&rft_id=info:doi/10.1186/2008-2231-21-34&rft_dat=%3Cgale_pubme%3EA534834387%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1365508714&rft_id=info:pmid/23635011&rft_galeid=A534834387&rfr_iscdi=true